These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27377469)

  • 1. CD24 is a genetic modifier for risk and progression of prostate cancer.
    Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
    Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
    Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
    World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
    Marchesani M; Hakkarainen A; Tuomainen TP; Kaikkonen J; Pukkala E; Uimari P; Seppälä E; Matikainen M; Kallioniemi OP; Schleutker J; Lehtimäki T; Salonen JT
    J Natl Cancer Inst; 2003 Jun; 95(11):812-8. PubMed ID: 12783936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
    Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
    Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
    Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
    Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells.
    Zhang W; Yi B; Wang C; Chen D; Bae S; Wei S; Guo RJ; Lu C; Nguyen LL; Yang WH; Lillard JW; Zhang X; Wang L; Liu R
    Clin Cancer Res; 2016 May; 22(10):2545-54. PubMed ID: 26712693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MnSOD AA Genotype with the Progression of Prostate Cancer.
    Iguchi T; Wang CY; Delongchamps NB; Kato M; Tamada S; Yamasaki T; de la Roza G; Nakatani T; Haas GP
    PLoS One; 2015; 10(7):e0131325. PubMed ID: 26147925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
    Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
    PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
    Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study].
    Zhou X; Cao Y; Luo J; Zeng X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1122-9. PubMed ID: 24316932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CD24-P226-C/T polymorphism and multiple sclerosis: a meta-analysis.
    Jiang L; Bai X; Wang Y; Wei M
    Immunol Invest; 2015; 44(4):321-30. PubMed ID: 25942344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese population.
    Sun H; Pan Y; Wu R; Lv J; Chi X; Wang X; Tu Z; Zhong J; Sun B; Liu Y; Jiang J; Niu J
    Liver Int; 2015 Mar; 35(3):786-94. PubMed ID: 25872416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
    Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
    Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.